Arcutis Biotherapeutics (ARQT) Stock Highlights

14.99 | +6.24%

2024-12-21 04:14:16

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The companys lead product candidate, roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Statistics

Range Today

14.18 15.79

Volume Today 5.22M

Range 1 Year

2.45 15.02

Volume 1 Year 813.86M

Range 3 Year

1.76 27.4

Volume 3 Year 1.38B

Range 10 Year

1.76 40.88

Volume 10 Year 1.47B

Highlights

Market Capitalization 1.27B (small)

Floating Shares 85.98M

Current Price 14.99

Price To Earnings -6.29

Price To Revenue 8.25

Price To Book 8.08

Earnings Per Share -1.67

Payout Ratio 0%

Performance

Latest +6.24%

1 Month +47.25%

3 Months +47.39%

6 Months +85.06%

1 Year +492.49%

3 Years -10.77%

5 Years -35%

10 Years -35%

Benchmarks

Market Capitalization

126 / 368

Gross Profits

112 / 278

Total Revenue

123 / 300

Total Rank

157 / 368

Free Cashflow

320 / 352

Performance 5 years

153 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.